Mass photometry recognized by U.S. Pharmacopeia in new AAV reference standards for gene therapy quality
USP employs mass photometry as key orthogonal method for empty/full characterization of AAV capsids Refeyn’s SamuxMP mass photometer for AAV analytics – used for characterizing the U.S. Pharmacopeia’s new adeno-associated virus (AAV) reference standards. Oxford, UK (18 June, 2025) – Refeyn announces that mass photometry has been recognized by the U.S. Pharmacopeia (USP)—and referenced in […]
New Comprehensive Brochure: Bioanalytics with Mass Photometry
The new Refeyn brochure is your complete guide to mass photometry solutions and services. The brochure includes: A brief explanation of how mass photometry and macro mass photometry work An overview of key applications A description of the products and services available from Refeyn Whether you are new to mass photometry or want to refine […]
StreamlineMP platform to speed up key bioanalytical workflows
Refeyn has developed and launched a custom software platform providing automated analysis of large mass photometry data sets. Refeyn’s new StreamlineMP software suite offers specialist analysis modules, automating data processing through standardized workflows for key bioanalytical applications to deliver more consistent results in a shorter time. StreamlineMP is a complementary modular software platform to […]
Mass photometry recognized for effective AAV analysis
The importance of effective adeno-associated virus (AAV) analysis – and how mass photometry can support this – has been recognized in recent publications.
